top of page
.jpg)
Search
News
BioTechNation Podcast - Fighting Cancer, Easing Pain... Dr. Lorin Johnson, CSO, Glycyx Therapeutics
This week on BioTech Nation, we explore a new approach to cancer treatment that could help patients manage pain without compromising...
May 8
Groundbreaking Research from UPMC Highlights Opioids’ Suppressive Impact on Immune Checkpoint Inhibitors and the Potential of Axelopran, an Opioid Antagonist to Reverse It
San Francisco, CA – December 04, 2024 – Glycyx, a clinical-stage biopharmaceutical company advancing axelopran, a novel solution to...
Dec 4, 2024
bottom of page